The purpose of the study is to assess the impact of HeartLogic-guided management on clinical outcomes among patients implanted with an eligible cardiac device.
Implanted with a CRT-D or ICD device that has HeartLogic capability and ability to change HeartLogic enablement per randomization
Age ≥18 years
Compliant with remote monitoring and not listed in the LATITUDE™ remote monitoring system as "not monitored"
None
Parallel
HeartLogic
Other interventionHeartLogic alerts will be managed according to a standardized alert management guide to ensure uniform reactions to HeartLogic alerts.
Composite endpoint of hospitalization for heart failure or all-cause death (first event)
Composite endpoint of hospitalization for heart failure or all-cause death (recurrent events)
Hospitalization for heart failure (first event)
All-cause hospitalization
All-cause mortality
Hospitalizations for heart failure (recurrent events)
Hierarchical composite of all-cause mortality, total number of heart failure hospitalizations, and total number of all-cause hospitalizations
All-cause readmission within 30 days after hospitalization for heart failure
Hospitalization for any cardiovascular disease
Click on the lead sponsor to view all of their trials.
Tor Biering-Sørensen
Lead sponsor
Herlev and Gentofte Hospital
Sponsor institution
Boston Scientific Corporation
Collaborator
